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Abstract
Surface expression of voltage-dependent K+ channels (Kv) has a pivotal role in leukocyte
physiology. Although little is known about the physiological role of lipid rafts, these
microdomains concentrate signaling molecules and their ion channel substrates. Kv1.3 associates
with Kv1.5 to form functional channels in macrophages. Different isoform stoichiometries lead to
distinct heteromeric channels which may be further modulated by targeting the complex to
different membrane surface microdomains. Kv1.3 targets to lipid rafts, whereas Kv1.5 localization
is under debate. With this in mind, we wanted to study whether heterotetrameric Kv1.5-containing
channels target to lipid rafts. While in transfected HEK-293 cells, homo- and heterotetrameric
channels targeted to rafts, Kv1.5 did not target to rafts in macrophages. Therefore, Kv1.3/Kv1.5
hybrid channels are mostly concentrated in non-raft microdomains. However, LPS-induced
activation, which increases the Kv1.3/Kv1.5 ratio and caveolin, targeted Kv1.5 back to lipid rafts.
Moreover, Kv1.5 did not localize to low-buoyancy fractions in L6E9 skeletal myoblasts, which
also coexpress both channels, heart membranes or cardiomyocyes. Coexpression of a Cav3DGV-
mutant confined Kv1.5 to Cav3DGV-vesicles of HEK cells. Contrarily, coexpression of Kvβ2.1
impaired the Kv1.5 targeting to raft microdomains in HEK cells. Our results indicate that Kv1.5
partnership interactions are underlying mechanisms governing channel targeting to lipid rafts.
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Introduction
Ion channels have differential surface distributions (Misonou and Trimmer, 2004). Lipid
rafts are specialized membrane microdomains rich in sphingolipids and cholesterol. Many
signal transduction enzymes known to modulate ion channels are concentrated in these
domains (Martens et al., 2004; Simons and Toomre, 2000). Caveolae are the best-
characterized rafts. These invaginated membrane structures contain caveolin, which interacts
directly with several intracellular proteins (Simons and Toomre, 2000). The localization of
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ion channels in caveolar-lipid rafts triggers rapid regulation of membrane excitability as the
caveolar neck opens, thus increasing the number of surface channels (Martens et al., 2004).
Voltage-gated potassium channels (Kv) set the membrane potential, and their subcellular
localization is necessary for proper electrical signalling (Misonou and Trimmer, 2004).
Several ion channels, and Kv in particular, target to lipid rafts (Martens et al., 2004). Kv2.1
was the first channel identified in rafts (Martens et al., 2000). Next, Kv1.5 was found to be
associated with caveolae (Martens et al., 2001). Since then, the list of channels associated
with caveolar or non-caveolar lipid rafts has been constantly growing. However, some
recent reports on Kv1.5 and Kv4.2 are contradictory, and suggest a complex scenario
(Eldstrom et al., 2006; Wong and Schlichter, 2004).
Kv1.3 plays a pivotal role in leukocyte responses (Cahalan et al., 2001). Kv1.3 is involved
in the maintenance of the resting membrane potential and plays a critical role during
activation and proliferation of leukocytes (Cahalan et al., 2001, Vicente et al., 2003). Upon
activation, Kv1.3 concentrates in the immunological synapse together with lipid rafts (Panyi
et al., 2004). Cholesterol regulates Kv1.3 gating, and the transformation of these rafts into
large ceramide-enriched membrane platforms inhibits channel activity (Bock et al., 2003;
Hajdu et al., 2003). On the other hand, Kv1.5, highly expressed in human atria, is involved
in the proliferation of astrocytes and myoblasts (MacFarlane and Sontheimer, 2000;
Villalonga et al., 2008) and plays a role during activation in mononuclear phagocytes
(Vicente et al., 2003; Vicente et al., 2005; Mullen et al., 2006; Pannasch et al., 2006;
Vicente et al., 2006). Kv1.3/Kv1.5 heteromeric association generates a plethora of distinct
channels, and the Kv1.3/Kv1.5 ratio plays a pivotal role in macrophage responses (Vicente
et al., 2006; Villalonga et al., 2007). Kv1.3 is associated with lipid rafts. However, the
association of Kv1.5 with caveolae is controversial. Therefore, our aim was to study the
targeting of Kv1.5 and heteromeric Kv1.5-containig channels to rafts in several cell systems,
including HEK-293 cells, macrophages, L6E9 myocytes, isolated cardiomyocytes and
membrane preparations from rat heart. In this article, we suggest that partnership interaction
mechanisms involving heteromeric associations, regulatory subunits or caveolin could alter
Kv1.5 targeting to lipid rafts.
Materials and methods
Cell culture and cardiomyocyte isolation
Raw 264.7 macrophages were cultured in RPMI containing 5% fetal bovine serum (FBS),
supplemented with antibiotics 10 U/ml penicillin and streptomycin, and 2 mM L-glutamine
(Vicente et al., 2006; Villalonga et al., 2007). Bone marrow-derived macrophages (BMDM)
were cultured in DMEM containing 20% FBS and 30% L-cell conditioned media as a source
of macrophage colony stimulating factor (Vicente et al., 2003). Macrophages were obtained
as a homogeneous population of adherent cells after 7 days in culture. Raw 264.7 and
BMDM were cultured in the absence or the presence of 100 ng/ml lipopolysaccharide (LPS)
for 24 hours. HEK-293 cells were cultured in DMEM containing 10% FBS and
supplemented as above (Vicente et al., 2006). L6E9 myoblasts (Dr. B. Nadal-Ginard, Mount
Sinai School of Medicine, NY) were grown in DMEM, supplemented as above plus 25 mM
Hepes (pH7.4) (Martinez-Marmol et al., 2007).
Hearts from Wistar rats (Harlan Interfauna Iberica) were excised and washed in ice-cold
0.9% NaCl. Calcium-tolerant myocytes were isolated by collagenase digestion. Hearts cut in
small pieces in Krebs Buffer (in mM: NaCl 119, KCl 5.4, CaCl2 1.5, KH2PO4 0.6, MgSO4
1.2, NaHCO3 25 and glucose 11.7) were washed 3 times in KB 0Ca (Ca2+ free) for 5 min.
Cardiac tissue was further incubated in KB 0Ca, supplemented with 200 U/ml collagenase
type IA and 0.03 mg/ml protease XIV (Sigma). The mixture was oxygenated with 95%
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O2/5% CO2 for 30 min, maintained at 37°C and gently shaken. Dispersed cells were filtered
with a nylon mesh and centrifuged. Cells were washed once in KB 0Ca. Animal handling
was approved by the ethics committee of the University of Barcelona, in accordance with
EU regulations.
DNA constructs, cell transfection, and immunocytochemistry
Rat pRcCMV-Kv1.3 cDNA was kindly donated by T.C. Holmes (New York University,
NY). Kv1.3-YFP and Kv1.5-CFP were generated as described (Vicente et al., 2006). Kvβ2.1
was characterised in Tamkun's laboratory (Uebele et al., 1996). Cav3DGV mutant was from
A. Pol (Universitat de Barcelona).
HEK-293 cells were transiently transfected using Lipofectamine 2000 (Invitrogen) to nearly
80% confluency, as described (Vicente et al., 2006). Twenty-four hours after transfection,
cells were washed with PBS (phosphate-buffered saline) and used for raft isolation or
immunocytochemistry. L6E9 myocytes and HEK-293 cells were grown on polylysine-
coated glass cover slips. L6E9 cells, fixed with cold methanol, were incubated with blocking
solution (10% goat serum/5% non fat dry milk/PBS) for 1h. Myocytes were reacted with
anti-Kv1.5 (Alomone), anti-Nav1.5 (Alomone) and anti-pan-caveolin (BD Transduction) in
10% goat serum/0.75% Triton X-100/PBS for 90 min. Cells were further incubated for 60
min with CY2 and CY3 secondary antibodies (Amersham). Preparations were fixed and
mounted with Aqua Poly/Mount (Polysciences).
Crude membrane preparations, raft isolation, and Western blot
Culture cells and cardiomyocytes were washed in cold PBS and lysed with ice-cold lysis
solution (1% Triton X-100, 10% glycerol, 50 mmol/L HEPES pH 7.5, 150 mmol/L NaCl)
supplemented with 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin and 1 mΜ
phenylmethylsulfonyl fluoride as protease inhibitors. To obtain enriched membrane
preparations, homogenates were centrifuged at 3,000 ×g for 10 min and the supernatant was
further centrifuged at 150,000 ×g for 90 min. The pellet was resuspended in 30 mM HEPES
(pH 7.4).
Fresh hearts were frozen in liquid nitrogen and powdered by a pestle and mortar. The
powder was homogenized in 4 mM HEPES (pH 7.0) and 320 mM sucrose supplemented
with protease inhibitors in a glass homogenizer. Nuclei and debris were pelleted at 2,000 ×g
for 10 min. The supernatant was centrifuged at 100,000 ×g for 1 h. The pellet was
resuspended in the same buffer (0.5 ml/g heart).
Culture cells, isolated cardiomyocytes, and crude membrane preparations were used for raft
isolation as described (Martens et al., 2000). Samples were homogenized in MES (2-
Morpholino ethanesulfonic acid)-buffered saline (24 mM MES, pH 6.5, and 0.15 mM NaCl)
plus 1% Triton X-100 and centrifuged at 3,000 g for 5 min at 4°C. Then sucrose was added
to achieve a final concentration of 40%. A 5-30% linear sucrose gradient was layered on top
and further centrifuged (39,000 rpm) for 20-22 h at 4°C in a Beckman SW41 rotor. Gradient
fractions (1ml) were collected from the top and analyzed by Western blot. In some
experiments, fractions were concentrated using Microcon centrifugal filter devices
(Amicon).
Sucrose fractions (50 μl) were boiled in Laemmli SDS loading buffer and separated on 10%
SDS-PAGE. They were transferred to nitrocellulose membranes (Immobilon-P, Millipore)
and blocked in 5% dry milk-supplemented 0.1% Tween 20 PBS before immunoreaction.
Filters were immunoblotted with antibodies against Kv1.3 (1/200, Alomone), Kv1.5 (1/500,
Alomone) and Nav1.5 (1/200, Alomone). Anti-pancaveolin antibody, which recognizes
caveolin 1, 2 and 3, and anti-flotillin-1 were used (1/1000) as markers of lipid raft fractions
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(BD Transduction). Since all kinds of lipid rafts are excluded from clathrin-positive regions
(Nichols 2003), filters were also probed with anti-clathrin antibody (Chemicon) to
characterize non-floating fractions (1/1000).
Results
Kv1.3, Kv1.5 and Kv1.3/Kv1.5 heteromers target to lipid rafts in HEK-293 cells
Kv1.3 concentrates in raft microdomains in T-cells, and Kv1.5 targets to caveolar-rafts in
fibroblasts (Bock et al., 2003; Folco et al., 2004; Martens et al., 2001; Panyi et al., 2004).
Since leukocytes and fibroblasts express Kvβ subunits, which are involved in channel
surface expression, we expressed Kv1.3 and Kv1.5 in HEK-293 cells. (Uebele et al., 1996;
Vicente et al., 2005). Kv1.3 and Kv1.5 colocalized with caveolin in HEK-293 cells (Fig. 1A,
C). Like fibroblasts and T-cells, channels targeted to low-buoyancy density fractions.
However, their presence in non-rafts is noticeable (Fig. 1B, D). Coexpression of Kv1.3 and
Kv1.5, which form heteromers, gave similar results (Fig. 1E, F). Similar results (not shown)
were obtained by a detergent-free lipid raft isolation protocol (Crossthwaite et al., 2005).
Kv1.3, but not Kv1.5, localized to lipid rafts in macrophages and skeletal muscle myocytes
Heterotetrameric Kv1.3/Kv1.5 channels contribute to the major Kv channel in macrophages
(Vicente et al., 2006). Kv1.3 targets to lipid raft in leukocytes, but the Kv1.5 caveolar-
localization is questioned in the heart (Bock et al., 2003; Eldstrom et al., 2006; Panyi et al.,
2004; Vicente et al., 2008). Fig 2 A demonstrates that Raw 264.7 and bone marrow-derived
macrophages (BMDM) shared the expression of Kv1.3 and Kv1.5. Unlike BMDM, Raw
264.7 macrophages did not express caveolin and rafts were identified with flotillin (Fig.
2A). Although Kv1.3 colocalized with flotillin in Raw cells (Fig 2B, C) and caveolin in
BMDM (Fig 2D, E), channels mostly concentrated in non-raft aliquots. Surprisingly, Kv1.5
was restricted to clathrin fractions (Fig 2B, D). In addition, Kv1.3/Kv1.5 heteromeric
association redistributed Kv1.3 to non-floating domains (Fig 2B-E). However, rafts
extractions from LPS-activated macrophages, which increases the Kv1.3/Kv1.5 ratio in the
heteromeric channel and induces caveolin expression in BMDM (Vicente et al., 2006),
showed that Kv1.5 appeared in low-buoyant density fractions (Fig. 2C, E).
Like macrophages, L6E9 myocytes coexpress Kv1.3 and Kv1.5 (Villalonga et al., 2008).
Furthermore, myocytes express caveolins and Kvβ subunits (Grande et al., 2003; Martinez-
Marmol et al., 2007). Both channels concentrated in non-floating fractions (Fig 3A). This
surprising result is in agreement with a limited Kv1.3 expression in L6E9 cells (Villalonga
et al., 2008). Therefore, we concentrated these fractions (Fig 3B). Concentrated high-sucrose
fractions were difficult to electrophorese. Nevertheless, Kv1.3 appeared in fractions 3 to 5,
whereas Kv1.5 did not colocalize with caveolin. This result was in contrast to that observed
in HEK cells, but clearly in agreement with macrophage results. Therefore, we analysed
Kv1.5 and caveolin colocalization in HEK and L6E9 cells (Fig. 4). The results confirmed
the raft-isolation studies. Unlike HEK cells, Kv1.5 did not colocalize with caveolin in
myoblasts (Fig 4A). In contrast, Nav1.5 colocalized with caveolin in L6E9 cells (Fig 4B)
indicating that, similarly to Kv1.3, this may be a regular location for this channel (Martens
et al., 2004; Martinez-Marmol et al., 2007).
Kv1.5 does not target to lipid rafts in heart and cardiomyocytes
Kv1.5 targets to lipid rafts (Abi-Char et al., 2007; Cogolludo et al., 2006; Folco et al., 2004;
Martens et al., 2001; McEwen et al., 2008). However, Fedida and coworkers failed to detect
Kv1.5 in rafts from cardiac samples (Eldstrom et al., 2006). Our results confirmed these
discrepancies. We investigated whether this channel targeted to low-buoyancy fractions in
isolated cardiomyocytes and crude membranes from rat heart (Fig 5). Unlike Nav1.5, Kv1.5
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did not colocalize with the lipid raft in isolated cardiomyocytes (Fig 5A) and heart
membranes (Fig 5B).
Cav3DGV confines Kv1.5, but not Kv1.3, to cholesterol-rich vesicles
While Kv1.5 localized in low-buoyancy fractions when expressed in HEK cells, Kv1.5
neither targeted to lipid rafts nor colocalized with caveolin in tissues and native cells.
However, an increase of Kv1.3 in heteromeric channels and an augmentation of caveolin
targeted Kv1.5 back to lipid rafts (see Fig. 2). Therefore, we coexpressed Kv1.3 and Kv1.5
with a Caveolin-3DGV mutant. This mutant generates Cav3-endoplasmic reticulum-related
and cholesterol-rich vesicles (Pol et al., 2001). Unlike Kv1.3 (Fig 6 A-C), Kv1.5
concentrated in Cav3DGV-vesicles (Fig 6 D-F). The association of Kv1.3 and Kv1.5
generated an intermediate pattern (Fig 6 G-J), confirming that, as in biophysics and
pharmacology, heteromerization modifies targeting and localization (Vicente et al.,
2006;Vicente et al., 2008). Cav3DGV-vesicles are enriched in cholesterol (Pol et al., 2001).
Therefore, channels were localized in low-buoyancy density fractions (Fig 6 K-M).
Kvβ2.1 redistributes Kv1.5 to non-floating domains
Contrary to what observed in HEK cells, Kv1.5 channels mostly localized out of lipid rafts
in native cells and tissues. While macrophages, myoblasts and heart share the expression of
cytoplasmic Kvβ subunits (Grande et al., 2003; Vicente et al., 2005), HEK-293 cells do not
(Uebele et al., 1996). Therefore, we coexpressed Kv1.5 and Kvβ2.1 in HEK cells. Kv1.5 and
Kvβ2.1 colocalised (Fig 7 A) and the presence of Kvβ2.1 impaired the Kv1.5 targeting to
raft fractions (Fig 7 B, C). In addition, some Kvβ2.1 localised in low-buoyancy density
fractions.
Discussion
Kv1.5 targets to lipid raft in HEK-293 cells but not in native tissues and cells.
In this work, we show that Kv1.5 targets to multiple membrane microdomains. Kv1.5
locates in low-buoyant density fractions in HEK 293 cells, but not in native cells
(macrophages and myocytes) and tissues (heart). However, while the regulatory Kvβ2.1
subunit redistributes Kv1.5 to non-floating domains in HEK cells, selective induction of
interacting proteins, such as Kv1.3 and caveolins, targeted Kv1.5 back to lipid rafts in
macrophages. This is in accordance with what we found by overexpressing Cav3DGV,
suggesting that partnership interactions regulate Kv1.5 trafficking to cholesterol-rich
membrane microdomains.
Kv1.3 and Kv1.5 locate in lipid rafts and caveolae in fibroblasts and leukocytes (Bock et al.,
2003; Cogolludo et al., 2006; Folco et al., 2004; Martens et al., 2001; Panyi et al., 2004).
Caveolae are specialized lipid rafts, which contain caveolins (Simons and Toomre, 2000).
Besides caveolins, fibroblasts also express Kvβ2.1 subunits, which are involved in surface
channel expression (Uebele et al., 1996). Not only Kv1.3 but also Kv1.5 associate to Kvβ
subunits (Uebele et al., 1996; Vicente et al., 2005). Therefore, we expressed Kv1.3 and
Kv1.5 in HEK-293 cells, which lack Kvβ (Uebele et al., 1996). In addition, HEK-293 cells
express caveolin 2, but the presence of caveolin 1 is scarce (Scherer et al., 1997). Therefore,
the number of caveolae is low (not shown). Like in fibroblasts and T-cells, channels targeted
to low-buoyancy density fractions in HEK cells. However, their presence in non-rafts was
abundant and was even higher in the presence of Kvβ2.1. Fedida and coworkers claim that
Kv1.5 does not target to rafts in HEK cells (Eldstrom et al., 2006). There is no clear
explanation for this discrepancy. However, it could be a consequence of caveolin-deficient
expression in the HEK-293 cell clone (Eldstrom et al., 2006). Indeed, Martens and
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coworkers recently described that caveolins govern Kv1.5 targeting to lipid rafts (McEwen
et al., 2008).
Heterotetrameric Kv1.3/Kv1.5 channels contribute to the major Kv channel in macrophages
(Vicente et al., 2006). Subunit association modulates channel targeting, leading to proper
electrical signalling (Misonou and Trimmer, 2004; Vicente et al., 2008). Since Kv1.3, but
not Kv1.5, was found in low-buoyant density fractions, our results confirm that Kv1.3 exists
as a homomeric channel in macrophages (Vicente et al., 2006; Villalonga et al., 2007). In
addition, Kv1.3/Kv1.5 heteromers redistributed Kv1.3 to non-floating domains (Fig 2A, B).
However, on activation, selective induction of Kv1.3 and caveolin targets heteromeric
channels back to rafts. Similarly, in myocytes, where Kv1.5 is much more abundant
(Villalonga et al., 2008), channels mostly concentrated in non-raft microdomains.
Does Kv1.5 target to lipid raft microdomains?
Kv1.5 co-immunoprecipitates with caveolin-1 in pulmonary artery smooth muscle cells
(Cogolludo et al., 2006). In addition, caveolin-3 and SAP97 form a scaffolding protein
complex in CHO cells (Folco et al., 2004). However, Eldstrom et al. (2006) described that
Kv1.5 does not target to rafts (Eldstrom et al., 2006). Our data in no way contradict previous
observations. While Kv1.5 localized in low-buoyancy fractions when expressed in HEK
cells, Kv1.5 neither targeted to lipid rafts nor colocalized with caveolin in tissues and native
cells. Similar discrepancies have been described with Kv4.2, which suggests the
involvement of underlying factors (Martens et al., 2000; Wong and Schlichter, 2004). A
possible mechanism links channels and nearby interacting elements.
Protein-protein interactions are implicated in the confinement of channels in lipid rafts. PDZ
(postsynaptic, disc large, zonula occludens) domain-containing proteins play a role in
targeting Kv channels to caveolar-rafts (Tiffany et al., 2000). PSD-95 and SAP97 interact
with Kv1.5 and recruit channels to a complex which includes caveolin-3 (Eldstrom et al.,
2002; Folco et al., 2004). Caveolins present binding domains (CBD) and signalling proteins
and channels with CBD localized in caveolae (Couet et al., 1997). Kv1.5 and Kv1.3 have
CBD near the T1 domain (FXXXXWXXF). It is not known to what extent these elements
are involved in caveolin-channel interactions. However, similar to what was found by
coexpressing Cav3DGV, Kv1.5 follows caveolin after microtubule disruption (Martens et al.,
2001) and exogenous caveolin expression (McEwen et al., 2008). Further partnership
mechanisms are Kvβ subunits, which stabilize channels on the cell surface (Martens et al.,
1999). Kvβ bind to channels at the T1 domain near CBDs (Gulbis et al., 2000). Therefore,
both proteins may compete.
Why does Kv1.5 target differently in heterologous expression and native systems? Our
results suggest that the presence of Kvβ subunits may impair the Kv1.5 localization in
caveolar-lipid rafts. Unlike native systems, HEK-293 cells lack Kvβ subunits (Uebele et al.,
1996). Therefore, the Kv1.5-CBD may be accessible. Fedida and coworkers found that
Kv1.5 did not target to rafts in their Kv1.5-HEK cell (Eldstrom et al., 2006). However, as
the authors point out, their HEK-293 cell line was defective in caveolin. We demonstrated
that overexpression of Cav3DGV concentrated Kv1.5. In fact, specific induction of Kv1.3 in
Kv1.3/Kv1.5 hybrid channels and caveolin targets back Kv1.5 to lipid rafts. On the contrary,
differential Kvβ expression may interfere with Kv1.5 targeting to rafts microdomains.
The findings of the present study are of interest, since K+ channels in leukocytes are
pharmacological targets in autoimmune diseases. While Kv1.3 efficiently targets to the lipid
raft, the presence of Kv1.5 in these microdomains depends on several factors, including
PDZ domain-containing proteins, caveolins, and Kvβ subunits. In macrophages, Kv1.3
associates with Kv1.5, and the Kv1.3/Kv1.5 ratio may change, leading to biophysically and
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pharmacologically distinct channels (Vicente et al., 2006; Villalonga et al., 2007).
Furthermore, different subunit stoichiometry may modulate the channel targeting to
microdomains enriched in signalling molecules. Kv1.3 redistributes in the presence of Kv1.5
(Vicente et al., 2008). Under different physiological stimuli, changes in the oligomeric
composition of functional Kv could have crucial effects on intracellular signals, determining
the specific macrophage response.
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Kv1.3 and Kv1.5 target to lipid rafts in HEK-293 cells. Cells were transfected with either
Kv1.3 (A,B) or Kv1.5 (C,D) or doubly-transfected with both channels (E,F). Kv1.3 (A),
Kv1.5 (C) and Kv1.3/Kv1.5 (E) channels colocalized with caveolin. Merge colours in E:
pink, merge of Kv1.3 and Kv1.5; white, merge of Kv1.3, Kv1.5 and caveolin. (B,D,F) Lipid
raft extractions. Kv1.3 (B), Kv1.5 (D) and Kv1.3/Kv1.5 (F) hybrids targeted to low-
buoyancy density sucrose fractions. Bars represent 10 μm.
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Kv1.3 and Kv1.5 channels differentially target to lipid rafts in macrophages. (A) Kv1.3,
Kv1.5, clathrin, flotillin and caveolin expression in Raw 264.7 and BMDM macrophages.
Sucrose density gradient fractions of Raw 264.7 macrophages (B,C) and BMDM (D,E)
cultured in the absence (B,D) or the presence of LPS (C,E). Kv1.3 localized with flotillin
(B,C) and caveolin (D,E), whereas Kv1.5 concentrated in non-raft fractions marked with
clathrin. (B-E). (C,F) Kv1.5 appeared in low-buoyant density fractions isolated from LPS-
induced macrophages.
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Kv1.3 and Kv1.5 channels differentially target to lipid rafts in L6E9 myocytes. Sucrose
density gradient fractions of L6E9 cells. (A) Fifty μl of each fraction were analyzed. (B)
Five hundred μl of each sucrose fraction were concentrated to 25 μl with Amicom devices.
While Kv1.3 appeared in fractions 3 to 5, Kv1.5 only concentrated in the non-raft fractions.
Longer film exposures impaired the visualization.
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Kv1.5 colocalizes with caveolin in HEK but not in L6E9 cells. (A) HEK cells transfected
with Kv1.5 and L6E9 cells were immunoreacted with anti-Kv1.5 and anti-pan-caveolin. (B)
Nav1.5 colocalizes with caveolin in L6E9 cells. Green, channels; red, caveolin; yellow,
colocalization. Bars represent 10 μm.
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Kv1.5 does not localize with lipid rafts in isolated cardiomyocytes and rat heart membranes.
(A) Cardiomyocytes and (B) membranes from rat heart were used for the lipid raft isolation.
While Kv1.5 does not target to low-buoyancy fractions, Nav1.5 is found in both raft and
non-raft fractions in rat heart membranes.
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Expression of Cav3DGV confines Kv1.5, but not Kv1.3, in Cav3DGV-vesicles. HEK cells
were cotransfected with Cav3DGV and Kv1.3, Kv1.5 or both. (A-C) Cav3DGV did not
modify Kv1.3 localization. (D-F) Coexpression of Kv1.5 and Cav3DGV. Kv1.5 concentrated
in Cav3DGV-vesicles. Colours: red, channels; green, Cav3DGV; yellow, colocalization of
channel and Cav3DGV. (G-J) Coexpression of Cav3DGV with Kv1.3 and Kv1.5 generated an
intermediate pattern. (G) Kv1.3; (H) Kv1.5; (I) Cav3DGV; (J) merge. Yellow, colocalization
of channels; white, triple colocalization of channels and Cav3DGV. Bars represent 10 μm.
(K-M) Kv1.3 and Kv1.5 target to low-buoyancy density fractions in Cav3DGV-transfected
HEK-293 cells. HEK cells were cotransfected with Cav3DGV together with Kv1.3 (K),
Kv1.5 (L) or doubly-transfected with both (M).
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Regulatory Kvβ2.1 subunit impairs Kv1.5 targeting to raft microdomains. HEK cells were
transfected with either Kv1.5-YFP or doubly-transfected with Kv1.5-YFP and Kvβ2.1-CFP
(ratio1:1). (A) Kv1.5 and Kvβ2.1 colocalized. Red, Kv1.5; green, Kvβ2.1; yellow, merge.
(B,C) Lipid raft extractions. Kv1.5 (B), Kv1.5/ Kvβ2.1 (C). The presence of Kvβ2.1
redistributes Kv1.5 to non-floating fractions. Bar represents 10 μm.
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